| Improved efficacy of neoadjuvant compared to adjuvant immunotherapy to eradicate metastatic disease J Liu, SJ Blake, MCR Yong, H Harjunpää, SF Ngiow, K Takeda, A Young, ... Cancer discovery 6 (12), 1382-1399, 2016 | 718 | 2016 |
| Antimetastatic effects of blocking PD-1 and the adenosine A2A receptor D Mittal, A Young, K Stannard, M Yong, MWL Teng, B Allard, J Stagg, ... Cancer research 74 (14), 3652-3658, 2014 | 273 | 2014 |
| Suppression of metastases using a new lymphocyte checkpoint target for cancer immunotherapy SJ Blake, K Stannard, J Liu, S Allen, MCR Yong, D Mittal, AR Aguilera, ... Cancer discovery 6 (4), 446-459, 2016 | 231 | 2016 |
| Immunosurveillance and therapy of multiple myeloma are CD226 dependent C Guillerey, LF De Andrade, S Vuckovic, K Miles, SF Ngiow, MCR Yong, ... The Journal of clinical investigation 125 (5), 2077-2089, 2015 | 156 | 2015 |
| Assessing immune-related adverse events of efficacious combination immunotherapies in preclinical models of cancer J Liu, SJ Blake, H Harjunpää, KA Fairfax, MCR Yong, S Allen, HE Kohrt, ... Cancer research 76 (18), 5288-5301, 2016 | 97 | 2016 |
| Improved Efficacy of Neoadjuvant Compared to Adjuvant Immunotherapy to Eradicate Metastatic Disease. Cancer Discov. 2016; 6: 1382–1399 J Liu, SJ Blake, MC Yong, H Harjunpää, SF Ngiow, K Takeda, A Young, ... CD-16-0577.[Abstract][Cross Ref], 0 | 78 | |
| DNA vaccine encoding HPV16 oncogenes E6 and E7 induces potent cell-mediated and humoral immunity which protects in tumor challenge and drives E7-expressing skin graft rejection J Chandra, JL Dutton, B Li, WP Woo, Y Xu, LK Tolley, M Yong, JW Wells, ... Journal of Immunotherapy (Hagerstown, Md.: 1997) 40 (2), 62, 2017 | 53 | 2017 |
| Dual stimulation of MyD88-dependent Toll-like receptors induces synergistically enhanced production of inflammatory cytokines in murine bone marrow-derived dendritic cells D Mitchell, M Yong, W Schroder, M Black, M Tirrell, C Olive The Journal of infectious diseases 202 (2), 318-329, 2010 | 43 | 2010 |
| NKT cells inhibit antigen-specific effector CD8 T cell induction to skin viral proteins SR Mattarollo, M Yong, C Gosmann, A Choyce, D Chan, GR Leggatt, ... The Journal of Immunology 187 (4), 1601-1608, 2011 | 42 | 2011 |
| Secretion of IFN-γ but not IL-17 by CD1d-restricted NKT cells enhances rejection of skin grafts expressing epithelial cell-derived antigen SR Mattarollo, M Yong, L Tan, IH Frazer, GR Leggatt The Journal of Immunology 184 (10), 5663-5669, 2010 | 37 | 2010 |
| Combined Anti-CD40 and Anti–IL-23 Monoclonal Antibody Therapy Effectively Suppresses Tumor Growth and Metastases B Von Scheidt, PSK Leung, MCR Yong, Y Zhang, JE Towne, MJ Smyth, ... Cancer research 74 (9), 2412-2421, 2014 | 35 | 2014 |
| Adoptive T Cell Therapy Targeting Different Gene Products Reveals Diverse and Context-Dependent Immune Evasion in Melanoma M Effern, N Glodde, M Braun, J Liebing, HN Boll, M Yong, E Bawden, ... Immunity, 2020 | 32 | 2020 |
| Suppression of metastases using a new lymphocyte checkpoint target for cancer immunotherapy. Cancer Discov. 2016; 6: 446–459. doi: 10.1158/2159-8290 SJ Blake, K Stannard, J Liu, S Allen, MC Yong, D Mittal, AR Aguilera, ... CD-15-0944.[Abstract][CrossRef][Google Scholar], 0 | 31 | |
| Co-blockade of immune checkpoints and adenosine A2A receptor suppresses metastasis A Young, D Mittal, K Stannard, M Yong, MWL Teng, B Allard, J Stagg, ... OncoImmunology 3 (10), e958952, 2014 | 29 | 2014 |
| Expression of a single, viral oncoprotein in skin epithelium is sufficient to recruit lymphocytes A Choyce, M Yong, S Narayan, SR Mattarollo, A Liem, PF Lambert, ... PloS one 8 (2), e57798, 2013 | 29 | 2013 |
| γδ T cells augment rejection of skin grafts by enhancing cross-priming of CD8 T cells to skin-derived antigen A Rahimpour, SR Mattarollo, M Yong, GR Leggatt, RJ Steptoe, IH Frazer Journal of Investigative Dermatology 132 (6), 1656-1664, 2012 | 22 | 2012 |
| Suppression of metastases using a new lymphocyte checkpoint target for cancer immunotherapy. Cancer Discov 2016; 6: 446-59; PMID: 26787820 SJ Blake, K Stannard, J Liu, S Allen, MC Yong, D Mittal, AR Aguilera, ... | 20 | |
| Toll-like receptor-mediated adjuvanticity and immunomodulation in dendritic cells: implications for peptide vaccines D Mitchell, M Yong, J Raju, N Willemsen, M Black, A Trent, M Tirrell, ... Human vaccines 7 (sup1), 85-93, 2011 | 17 | 2011 |
| Expression of maturation markers on murine dendritic cells in response to group A streptococcal lipopeptide vaccines M Yong, D Mitchell, A Caudron, I Toth, C Olive Vaccine 27 (25-26), 3313-3318, 2009 | 8 | 2009 |
| Abstract B115: Improved efficacy of neoadjuvant compared to adjuvant immunotherapy to eradicate metastatic disease J Liu, S Blake, M Yong, H Harjunpaa, SF Ngiow, K Takeda, A Young, ... Cancer Immunology Research 4 (11 Supplement), B115-B115, 2016 | | 2016 |
